Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
July 30th? So would Trumps admin announcement “early this week” steal the NP Thunder or is he announcing lenzilumab?
These gov guys hand out Covid teases daily. Just another two weeks now... almost there.
We need an OANN reporter to name drop LL and shock Trump in the briefings to at least see his poker face.
Having Sanofi as a partner in trials would help tremendously. NP is still struggling with the pharma landscape with the FDA. Need some experience at the wheel.
Not yet... too soon. But the offer is not far off. CytoDyn would be wise not to take it. Pretty sure it would require a shareholder vote to approve.
Yep, no doubt. It’s all BS speculation and you only get what someone is willing to pay. That and ihub is a tiny unknown island of opinion. Kinda like the Mos Eisley Cantina in Star Wars
Russia is a last resort shot at US relevance. Could easily be sanctioned which would be against humanitarian guidelines but still could happen.
Sounds like Trump wants an announcement this week on therapeutics. There’s only two in play and that’s Lenzilumab and Leronlimab. Lenzil helps but is a 2nd place finisher to Leron.
Leron has multiple indications where Lenzil does not. Lenzil is likely undercutting Leron on the asking price which short term counters NP leverage. Don’t think that BP isn’t using that against NP this weekend. Vice versa for Lenzil but Leron has a stronger hand.
Yep, I like to flip this stock but I won’t over the next three weeks. If they don’t have approval in hand by then it’s obvious there’s an entity blocking CytoDyn.
Licensing opens up the doors for BP to get their taste of the pie and when BP wins then LL floods the market.
All should understand that the science is not in question.... it’s who will profit and that is the holdup right now.
NP holds the cards but BP owns the table. Can’t win if you can’t play.
Can’t divulge that but I think it’s not going anywhere with NP at the helm. Let’s just say I’m in the business and obviously HAART is heavily invested in. LL poses a clear and present danger to billions of leveraged research. This we know. These conversations are ongoing with our BOD connections, it’s been ongoing since 2018. NP likes to name drop to keep the SP up, but I think it’s heating up as the LL cat peeks out of the bag.
A buyout doesn’t make sense anyway due to LL multi indications. It needs to be licensed appropriately for the indications. Doesn’t make sense for one BP to own the multi indications and it hints at anti-trust investigations. Cancer, HIV, NASH, ARDS, vaccines... etc... I know medical professionals that are saying this could be revolutionary medicine. Add in those already on YouTube and I’m surprised it’s not getting eaten up like candy at these prices.
It is nice to see the likes of BP realize that Covid is potentially providing funding to a market disruptor and time is running out on snuffing it or getting exclusivity rights.
There are other CCR5 blockers in BP inventory but none have the safety of LL and that’s important in sick cancer, HIV patients.
You likely know this already.
My prediction is no buyout but multiple licensing agreements with 2-3 BPs.
In the stock market, especially the OTC, there is little law.
NP and BOD entertaining offers this weekend. Minimum PPS is $100 and that’s a bargain with all indications priced in.
This is a home run stock... if the corrupt world will allow it to be one.
Sadly, lives depend on its freedom.
If Mexico gets approval first look for black market LL in the SW. Just like weed, lol.
JG bangin the drum... he’s fired up and he can smell the money
It’s sickening how cultish those Covid hoaxers have become. I’m no fan of Fauci but jeez ... he’s just a bureaucrat now. Definitely not a pitcher.
Yep, no doubt it was a coordinated illegal attack. Equivalent to a stage coach robbery in the old west. Same result.... no one will go to jail.
This was bluntly obvious to even the greenest of traders. If anyone states otherwise then ... yes I have some wonderful MLM products they should buy.
Calls for a 2nd USA shutdown are growing. Tick tock FDA.... LL can save your ass.
Quite possible... it’ll be nice to hear less drama.
Agreed. Quarterly won’t show much IMO except horrible Covid data. The next quarter should be interesting.
If they could file without an NT? That would be a BS win.... lol, but a win nonetheless.
Balance is key no doubt. If you do that on a stock BB you’ll get the wrath of the Kool Aid drinkers or just get labeled a FUDD or short position.
The science of LL is sound, it’s the biz/drug development that is in play. Doesn’t matter what we say here unless it’s gets implemented by the board/CEO.
The above is just common sense, but it has to be said daily on most BBs. If played correctly with a strong tailwind the sky is the limit on market cap. Imagine being Usain bolt at a high school track meet.... there’s still ways to lose this.
Patents only last 20 years.... if you have the # look at the exp date.
TDS... there’s no cure
This ..... come on FDA let’s go already
Maybe next year...
He usually does over promise... any good BP CEO should just say could happen any day now. Wink!
Not necessarily... although if it goes into late next week then that’s enough.
Spot on!
When does trump announce that leronlimab is the new SOC?
Clock is ticking if he wants elected again... senior citizens in Florida are bailing on him. 3 months to go...
Get off the OTC so real investors can buy this stock.... by real I mean institutional. Then you’ll see explosive PPs growth. OTC flippers won’t get ya too far but they can get you to $1. The float has to be locked up though.
That would impact them extremely negatively in market timing and rollout. Doubt they would do that to themselves at this critical point in Covid time.
Supposed to... although I like that they don’t say when as it keeps the shorts in line.
Both are viable anecdotally against Covid. We have no clinical data on either for efficacy.
If NP drags his feet on releasing data it’ll get ugly here as trust will wane and shorts smell blood.
It’s about a month behind... and they are three months behind on releasing a therapeutic
Do us a favor and run that by Bruce Patterson and get back to us. Thanks!
If the PRs are true then Revs are 700million a year.
Yeah and I’ll bet BigPharma is asking NP if they can see the data before it’s released. That’ll take time too
Aug 4th is what? Merger close or just a social media launch?
.70 is possible IF PRs about the 3000 are correct.
No complaints from me... I’m sitting in the green healthy.
But you know how it goes... investing is about growth. We’ll see if NP can learn new skills and be a BP CEO.
Thanks Pony, I’m glad someone is talking with him.
I bought shares at a dime ask just to see what’s hidden.
My pals talked with Saunders and tried the number on the website. Neither got Chas to call back.
Isn’t the 10k due very soon? Will he file?
Anyone notice that the ask is now 10 cents? Did the MMs just give up lol?
And yes a new CEO would succumb to the BOD and banks and dilute more... no doubt. But maybe that’s what the business needs to grow?
No guarantees in life... but growth requires change sometimes. Same guy who grows isn’t always the same guy who cares for it. All can contribute still... and get paid.
Maybe they’ll let Nader choose his replacement ... who knows. As a BOD member he would have to have a say.
Just food for thought.... don’t be surprised if it happens and buy the unrealistic dip in SP.
The BOD will eventually come to realize NP has served valiantly but can’t take this further..
A new CEO will come along and NP will move to a lucrative BOD role. All will be happy.
Who is the next CEO? Let’s hope someone with BP experience who won’t sabotage the science.